These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32152451)

  • 21. Clofibrate and the fibrinolytic system. (2).
    Chakrabarti R; Fearnley GR
    Lancet; 1969 Feb; 1(7588):263-4. PubMed ID: 4178627
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
    Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
    Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fibrinolytic inhibitors].
    Nagamatsu A
    Saishin Igaku; 1966 Feb; 21(2):320-5. PubMed ID: 5966316
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinolytic therapy: biochemical mechanisms.
    Robbins KC
    Semin Thromb Hemost; 1991 Jan; 17(1):1-6. PubMed ID: 1828622
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism.
    Cellai AP; Lami D; Antonucci E; Fiorillo C; Becatti M; Olimpieri B; Bani D; Grifoni E; Cenci C; Marcucci R; Mannini L; Poli D; Abbate R; Prisco D
    Thromb Haemost; 2013 Mar; 109(3):565-7. PubMed ID: 23306795
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemostasis associated with abnormalities of fibrinolysis.
    Aoki N
    Blood Rev; 1989 Mar; 3(1):11-7. PubMed ID: 2650772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental studies on the production of pulmonary infarction. IV. Effects of UK, heparin, t-AMCHA or ellagic acid.
    Hasegawa H; Watanabe N; Kakizaki H; Murata H
    Jpn Heart J; 1973 Jul; 14(4):335-49. PubMed ID: 4542948
    [No Abstract]   [Full Text] [Related]  

  • 29. Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro.
    Van Leer C; Stutz M; Haeberli A; Geiser T
    Thromb Haemost; 2005 Dec; 94(6):1257-64. PubMed ID: 16411403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heparin effect on hydrolysis of fibrin clots in a bull and a man with varying fibrinolytic systems].
    Makogonenko EM
    Ukr Biokhim Zh (1978); 1997; 69(5-6):109-16. PubMed ID: 9606832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 4. Antifibrinolytic action of sex hormones, especially a conjugated estrogen (Premarin) and its application.
    Mori N; Takemoto J
    Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):137-42. PubMed ID: 4309742
    [No Abstract]   [Full Text] [Related]  

  • 32. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA; Barry KJ; Stein BM
    Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on the fibrinolytic activity of the cerebrospinal fluid and the effect of PAMBA].
    Hellinger J; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):61-6. PubMed ID: 4173882
    [No Abstract]   [Full Text] [Related]  

  • 35. The fibrinolytic system.
    Fearnley GR
    Proc R Soc Med; 1971 Sep; 64(9):923-5. PubMed ID: 5114291
    [No Abstract]   [Full Text] [Related]  

  • 36. Importance of fibrin specificity in therapeutic thrombolysis and the rationale of using sequential and synergistic combinations of tissue plasminogen activator and pro-urokinase.
    Gurewich V
    Semin Thromb Hemost; 1989 Apr; 15(2):123-8. PubMed ID: 2501871
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation].
    Deutschinoff A; Dimitrov D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):166-73. PubMed ID: 4174654
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thrombolytic therapy].
    Schmutzler R; Koller F
    Ergeb Inn Med Kinderheilkd; 1965; 22():157-210. PubMed ID: 5889464
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fibrinolytic diathesis following surgery of the prostate].
    Ambroz W; Kuznik Z; Polubiec A
    Pol Przegl Chir; 1967 Oct; 39(10):Suppl:1098+. PubMed ID: 6080893
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
    Frick G; Frick U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.